Table 1 Demographic features and disease characteristics of participants
From: Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
Variable | n (%) | Mean ± SD | Median |
|---|---|---|---|
Age (y) | 41.9 ± 12.85 | ||
Nulliparous | 16 (48.48%) | ||
Preoperative serum CA-125 (n = 30) | 39.9 (8-1037) | ||
< 35 IU/L | 13 (43.33%) | ||
> 35 IU/L | 17 (56.67%) | ||
Tumor diameter (cm) | 7.3 ± 4.56 | ||
Surgical extent | |||
Conservative surgery | 17 (51.52%) | ||
Radical | 16 (48.48%) | ||
Staging surgery | 18 (54.55%) | ||
Stage | |||
I | 31b (93.94%) | ||
II-III | 2 (6.06%) | ||
Histological feathers | |||
Stromal microinvasion | 7 (21.21%) | ||
Intraepithelial carcinoma | 4 (12.12%) | ||
Implants | 2c (6.06%) | ||
Coexisting endometriosis | 10 (30.30%) | ||
Endometrial evaluations | 25 (75.76%) | ||
No lesions | 12 (48.00%) | ||
Hyperplasia without atypia | 2 (8.00%) | ||
EIN | 5 (20.00%) | ||
Endometrial cancer | 6 (24.00%) | ||
Additional treatment | |||
Chemotherapy | 10d (30.30%) | ||
Radiotherapy | 3 (9.09%) | ||